726 related articles for article (PubMed ID: 17545385)
1. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity.
Chorne N; Leonard C; Piecuch R; Clyman RI
Pediatrics; 2007 Jun; 119(6):1165-74. PubMed ID: 17545385
[TBL] [Abstract][Full Text] [Related]
2. Outcome of patent ductus arteriosus ligation in premature infants in the East of England: a prospective cohort study.
Kang SL; Samsudin S; Kuruvilla M; Dhelaria A; Kent S; Kelsall WA
Cardiol Young; 2013 Oct; 23(5):711-6. PubMed ID: 23164413
[TBL] [Abstract][Full Text] [Related]
3. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias.
Mirea L; Sankaran K; Seshia M; Ohlsson A; Allen AC; Aziz K; Lee SK; Shah PS;
J Pediatr; 2012 Oct; 161(4):689-94.e1. PubMed ID: 22703954
[TBL] [Abstract][Full Text] [Related]
4. Patent ductus arteriosus ligation in premature infants: who really benefits, and at what cost?
Raval MV; Laughon MM; Bose CL; Phillips JD
J Pediatr Surg; 2007 Jan; 42(1):69-75; discussion 75. PubMed ID: 17208543
[TBL] [Abstract][Full Text] [Related]
5. [Patent ductus arteriosus in premature infants].
Bratlid D; Farstad T
Tidsskr Nor Laegeforen; 2009 Aug; 129(15):1455-8. PubMed ID: 19690594
[TBL] [Abstract][Full Text] [Related]
6. Incidence and clinical features of patent ductus arteriosus in low-birthweight infants: a prospective analysis of 150 consecutively born infants.
Siassi B; Blanco C; Cabal LA; Coran AG
Pediatrics; 1976 Mar; 57(3):347-51. PubMed ID: 1256945
[TBL] [Abstract][Full Text] [Related]
7. Effect of persistent patent ductus arteriosus on mortality and morbidity in very low-birthweight infants.
Tauzin L; Joubert C; Noel AC; Bouissou A; Moulies ME
Acta Paediatr; 2012 Apr; 101(4):419-23. PubMed ID: 22133090
[TBL] [Abstract][Full Text] [Related]
8. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes.
Laughon M; Bose C; Clark R
J Perinatol; 2007 Mar; 27(3):164-70. PubMed ID: 17251985
[TBL] [Abstract][Full Text] [Related]
9. Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management.
Brooks JM; Travadi JN; Patole SK; Doherty DA; Simmer K
Arch Dis Child Fetal Neonatal Ed; 2005 May; 90(3):F235-9. PubMed ID: 15846015
[TBL] [Abstract][Full Text] [Related]
10. Is there an optimal timing for surgical ligation of patent ductus arteriosus in preterm infants?
Vida VL; Lago P; Salvatori S; Boccuzzo G; Padalino MA; Milanesi O; Speggiorin S; Stellin G
Ann Thorac Surg; 2009 May; 87(5):1509-15; discussion 1515-6. PubMed ID: 19379895
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?
Cordero L; Nankervis CA; Delooze D; Giannone PJ
J Perinatol; 2007 Mar; 27(3):158-63. PubMed ID: 17251986
[TBL] [Abstract][Full Text] [Related]
12. The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates: size matters.
Tschuppert S; Doell C; Arlettaz-Mieth R; Baenziger O; Rousson V; Balmer C; Prêtre R; Dodge-Khatami A
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):78-82. PubMed ID: 18179922
[TBL] [Abstract][Full Text] [Related]
13. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
Cordero L; Nankervis CA; Gardner D; Giannone PJ
J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778
[TBL] [Abstract][Full Text] [Related]
14. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants.
Noori S; McCoy M; Friedlich P; Bright B; Gottipati V; Seri I; Sekar K
Pediatrics; 2009 Jan; 123(1):e138-44. PubMed ID: 19117835
[TBL] [Abstract][Full Text] [Related]
15. [Patent ductus arteriosus. A common clinical problem in extremely premature infants].
Edstedt-Bonamy AK; Johansson S; Milerad J
Lakartidningen; 2000 Dec; 97(49):5756-61. PubMed ID: 11188032
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of sterile water by gavage drip in the fluid management of extremely low birth weight infants.
Stewart CD; Morris BH; Huseby V; Kennedy KA; Moya FR
J Perinatol; 2009 Jan; 29(1):26-32. PubMed ID: 18754014
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for persistent ductus arteriosus patency during indomethacin treatment.
Chorne N; Jegatheesan P; Lin E; Shi R; Clyman RI
J Pediatr; 2007 Dec; 151(6):629-34. PubMed ID: 18035143
[TBL] [Abstract][Full Text] [Related]
18. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study.
Dollberg S; Lusky A; Reichman B
J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):184-8. PubMed ID: 15699694
[TBL] [Abstract][Full Text] [Related]
19. Effects of low oxygen saturation limits on the ductus arteriosus in extremely low birth weight infants.
Noori S; Patel D; Friedlich P; Siassi B; Seri I; Ramanathan R
J Perinatol; 2009 Aug; 29(8):553-7. PubMed ID: 19461594
[TBL] [Abstract][Full Text] [Related]
20. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.
Madan JC; Kendrick D; Hagadorn JI; Frantz ID;
Pediatrics; 2009 Feb; 123(2):674-81. PubMed ID: 19171637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
